Recommendations on Management of Locally Advanced Rectal Cancer During the COVID-19 Pandemic : an Iranian Consensus
PURPOSE: Today, the rapid outbreak of COVID-19 is the leading health issue. Patients with cancer are at high risk for the development of morbidities of COVID-19. Hence, oncology centers need to provide organ-based recommendations for optimal management of cancer in the COVID-19 era.
METHODS: In this article, we have provided the recommendations on management of locally advanced rectal cancer during the COVID-19 pandemic based on our experience in Shohada-e Tajrish Hospital, Iran.
RESULTS: We recommend that patients with locally advanced rectal cancer should be managed in an individualized manner in combination with local conditions related to COVID-19.
CONCLUSION: Our recommendation may provide a guide for oncology centers of developing countries for better management of locally advanced rectal cancer.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2020 |
|---|---|
| Erschienen: |
2020 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:51 |
|---|---|
| Enthalten in: |
Journal of gastrointestinal cancer - 51(2020), 3 vom: 13. Sept., Seite 800-804 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Siavashpour, Zahra [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
COVID-19 |
|---|
| Anmerkungen: |
Date Completed 07.08.2020 Date Revised 18.02.2022 published: Print Citation Status MEDLINE |
|---|
| doi: |
10.1007/s12029-020-00454-4 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM312333366 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM312333366 | ||
| 003 | DE-627 | ||
| 005 | 20231225144207.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2020 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1007/s12029-020-00454-4 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1041.xml |
| 035 | |a (DE-627)NLM312333366 | ||
| 035 | |a (NLM)32656628 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Siavashpour, Zahra |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Recommendations on Management of Locally Advanced Rectal Cancer During the COVID-19 Pandemic |b an Iranian Consensus |
| 264 | 1 | |c 2020 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 07.08.2020 | ||
| 500 | |a Date Revised 18.02.2022 | ||
| 500 | |a published: Print | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a PURPOSE: Today, the rapid outbreak of COVID-19 is the leading health issue. Patients with cancer are at high risk for the development of morbidities of COVID-19. Hence, oncology centers need to provide organ-based recommendations for optimal management of cancer in the COVID-19 era | ||
| 520 | |a METHODS: In this article, we have provided the recommendations on management of locally advanced rectal cancer during the COVID-19 pandemic based on our experience in Shohada-e Tajrish Hospital, Iran | ||
| 520 | |a RESULTS: We recommend that patients with locally advanced rectal cancer should be managed in an individualized manner in combination with local conditions related to COVID-19 | ||
| 520 | |a CONCLUSION: Our recommendation may provide a guide for oncology centers of developing countries for better management of locally advanced rectal cancer | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Review | |
| 650 | 4 | |a COVID-19 | |
| 650 | 4 | |a Chemotherapy | |
| 650 | 4 | |a Radiotherapy | |
| 650 | 4 | |a Rectal cancer | |
| 700 | 1 | |a Taghizadeh-Hesary, Farzad |e verfasserin |4 aut | |
| 700 | 1 | |a Rakhsha, Afshin |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Journal of gastrointestinal cancer |d 2007 |g 51(2020), 3 vom: 13. Sept., Seite 800-804 |w (DE-627)NLM182605981 |x 1941-6636 |7 nnns |
| 773 | 1 | 8 | |g volume:51 |g year:2020 |g number:3 |g day:13 |g month:09 |g pages:800-804 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1007/s12029-020-00454-4 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 51 |j 2020 |e 3 |b 13 |c 09 |h 800-804 | ||